Status:
COMPLETED
ESD Versus EMR for Treatment of Early Barrett's Adenocarcinoma
Lead Sponsor:
Evangelisches Krankenhaus Düsseldorf
Conditions:
High Grade Intraepithelial Neoplasia
Barrett Adenocarcinoma
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Conventional techniques of endoscopic mucosal resection (EMR) by snare resection do usually not achieve resection of gastrointestinal mucosal neoplastic lesions larger than 1 cm in diameter in a singl...
Detailed Description
Conventional techniques of endoscopic mucosal resection (EMR) by snare resection do usually not achieve resection of gastrointestinal mucosal neoplastic lesions larger than 1 cm in diameter in a singl...
Eligibility Criteria
Inclusion
- Male, Female
- At least 18 years old
Exclusion
- \- Age under 18 years
- Health status ASA 4
- Pregnancy
- INR\>2.0, Platelets \< 70/nl
- Previous endoscopic or surgical treatment of BE neoplasia
- Neoplastic lesions which do not meet the inclusion criteria, in particular flat lesions (type 0-IIb)
- Additional areas of HGIN or AC
- Absence of a signed informed consent
Key Trial Info
Start Date :
December 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2015
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT01871636
Start Date
December 1 2012
End Date
August 1 2015
Last Update
September 9 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Evangelisches Krankenhaus
Düsseldorf, Germany, 40217